Eli Lilly

Eli Lilly: Plenty of Talk, Now Time for Results
Seeking Alpha
Wed, 02/16/11 - 09:44 am
Eli Lilly
Eli Lilly funds aim to share research costs
FT.com
Mon, 02/14/11 - 11:22 am
Eli Lilly
R&D
Lilly's HR/diversity chief chosen to head its cancer drug business
Indianapolis Star, IN
Sun, 02/13/11 - 11:03 am
Eli Lilly
Lilly CEO Criticizes Pace of R&D
Seeking Alpha
Sat, 02/12/11 - 12:19 pm
Eli Lilly
The $15 Billion Biotech Blockbuster Whose Sales Are Going Up With No End In Sight
Forbes
Fri, 02/11/11 - 07:43 am
diabetes
insulin
Merck
GSK
Novo Nordisk
Eli Lilly
Hard Luck: Why Viagra Is About to Lose Its No.1 Status to Cialis
BNET Pharma
Thu, 02/10/11 - 10:09 am
Viagra
erectile dysfunction
Pfizer
Eli Lilly
Cialis
FDA Says Drug Firms Didn't Finish Follow-Ups
WSJ Online
Wed, 02/9/11 - 11:16 am
FDA
cancer
Roche
GSK
Eli Lilly
AstraZeneca
Amgen
Eli Lilly CEO Rejects Corporate Jet Perk, Unlike His Peers
BNET Pharma
Tue, 02/8/11 - 11:51 am
Eli Lilly
Pharma CEOs
John Lechleiter
Drugs for Schizophrenia May Lead to Brain Tissue Loss
Bloomberg
Mon, 02/7/11 - 07:25 pm
JNJ
schizophrenia
AstraZeneca
Risperdal
Zyprexa
Seroquel
Eli Lilly
Boost for Shire's ADHD Franchise
Yahoo/Zacks.com
Mon, 02/7/11 - 07:23 pm
ADHD
Eli Lilly
JNJ
Vyvanase
Lilly Ties Employee Bonus To R&D Pipeline
Pharmalot
Mon, 02/7/11 - 08:45 am
Eli Lilly
bonuses
R&D
Lilly Will Tie Bonuses to Drug Development in Face of Generic Competition
Bloomberg
Sat, 02/5/11 - 11:08 am
Eli Lilly
Value Pharma Stocks in Overpriced Market
Seeking Alpha
Sat, 02/5/11 - 10:59 am
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
Lilly, Bristol-Myers halt drug study enrollment
Yahoo/AP
Wed, 02/2/11 - 03:09 pm
Eli Lilly
Bristol-Myers Squibb
cancer
necitumumab
Four Pharma Stocks With Appealing Value, Dividend Yield
Seeking Alpha
Wed, 02/2/11 - 09:08 am
Eli Lilly
Merck
Pfizer
Bristol-Myers Squibb
dividends
Sanofi Diabetes Drug Worked as Well as Byetta in Study
Bloomberg
Wed, 02/2/11 - 08:42 am
Sanofi
diabetes
Byetta
lixisenatide
Amylin
Eli Lilly
5 Drugmakers Headed Back to the Drawing Board
Motley Fool
Mon, 01/31/11 - 06:54 pm
Bydureon
Eli Lilly
Amylin
diabetes
MannKind
Afrezza
InterMune
Esbriet
IPF
Lorqess
Arena Pharmaceuticals
Vivus
Qnexa
A Foursome Of Pharma Earnings Suggests Business Is Still Tough
Investopedia
Mon, 01/31/11 - 05:07 pm
earnings
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
MannKind
Novartis
Vivus
Avoid This Falling Knife for Now (Eli Lilly)
Motley Fool
Sat, 01/29/11 - 11:52 am
Eli Lilly
investors
Lilly Profit Increases More Than Analysts Estimated
Bloomberg
Thu, 01/27/11 - 08:51 am
Eli Lilly
earnings

Pages